FdaApplication
ANDA 065390
Identifiers
- fda_app_no: ANDA065390
Properties
| Property | Value |
|---|---|
| applicant_name | CHARTWELL MOLECULAR HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2008-03-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFAMPIN | RIFAMPIN | 150MG | CAPSULE;ORAL |
| RIFAMPIN | RIFAMPIN | 300MG | CAPSULE;ORAL |
2 products